['lizbeth]

I asked the San Antonio Med Ctr nurses for the latest status of the clinical trials and here is my understanding of what is open for Her2 3+ (which is us, the Her2+++).

Walter Reed Vaccine trial:

"If a patient is HER2 3+ and HLA A2+ then she would qualify for the study. If she is Her2 3+ and HLA A2-she would NOT qualify for the study. Don't forget there are several other inclusion/exclusion criteria that she may have not met. Also, there are only 3 sites open to enrollment at this time due to the trial being almost fully enrolled and Walter Reed is not one of them. It is us at SAMMC, MD Anderson in Houston and I can't remember the 3rd at this time, but I will ask and let you know.

At this time you can still enroll for AE37 at MD Anderson. They are looking to close the trial to enrollment by the end of the year." (this is the Phase II HER2 3+ HLA A2- group).

So it appears that the "not qualifying" is based on full enrollment at specific sites.